|
|
Volumn 221, Issue 11, 2020, Pages 1770-1774
|
|
Clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in Shenzhen, China
a
|
|
Author keywords
Asymptomatic infection; Outcome; SARS coronavirus 2
|
|
Indexed keywords
C REACTIVE PROTEIN;
INTERLEUKIN 6;
LACTATE DEHYDROGENASE;
PROCALCITONIN;
ANTIVIRUS AGENT;
LOPINAVIR;
LOPINAVIR-RITONAVIR DRUG COMBINATION;
RITONAVIR;
ADULT;
ARTICLE;
ASYMPTOMATIC INFECTION;
BLOOD CELL COUNT;
BLOOD CLOTTING;
CHINA;
CLINICAL OUTCOME;
COMORBIDITY;
CONTROLLED STUDY;
CORONAVIRUS DISEASE 2019;
DISEASE CLASSIFICATION;
ELECTROLYTE BLOOD LEVEL;
EPIDEMIOLOGICAL DATA;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
HOSPITAL ADMISSION;
HUMAN;
HUMAN CELL;
KIDNEY FUNCTION;
LIVER FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
NONHUMAN;
NUCLEIC ACID ANALYSIS;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RETROSPECTIVE STUDY;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;
THROAT CULTURE;
VIRAL CLEARANCE;
ADOLESCENT;
AGED;
BETACORONAVIRUS;
CHILD;
CORONAVIRUS INFECTION;
DISEASE EXACERBATION;
DRUG COMBINATION;
HOSPITALIZATION;
MIDDLE AGED;
PANDEMIC;
PATHOLOGY;
PRESCHOOL CHILD;
TIME FACTOR;
TREATMENT OUTCOME;
VIRUS PNEUMONIA;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
ANTIVIRAL AGENTS;
ASYMPTOMATIC INFECTIONS;
BETACORONAVIRUS;
CHILD;
CHILD, PRESCHOOL;
CHINA;
CORONAVIRUS INFECTIONS;
DISEASE PROGRESSION;
DRUG COMBINATIONS;
FEMALE;
HOSPITALIZATION;
HUMANS;
LOPINAVIR;
MALE;
MIDDLE AGED;
PANDEMICS;
PNEUMONIA, VIRAL;
RETROSPECTIVE STUDIES;
RITONAVIR;
TIME FACTORS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 85083185253
PISSN: 00221899
EISSN: 15376613
Source Type: Journal
DOI: 10.1093/infdis/jiaa119 Document Type: Article |
|
Times cited : (237)
|
|
References (15)
|
